148 related articles for article (PubMed ID: 17293900)
21. Nosocomial MRSA pneumonia: data from recent clinical trials.
Karvouniaris M; Makris D; Karabekos D; Zakynthinos E
Rev Recent Clin Trials; 2011 Sep; 6(3):235-40. PubMed ID: 21682676
[TBL] [Abstract][Full Text] [Related]
22. Health economic evaluation of patients treated for nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus: secondary analysis of a multicenter randomized clinical trial of vancomycin and linezolid.
Niederman MS; Chastre J; Solem CT; Wan Y; Gao X; Myers DE; Haider S; Li JZ; Stephens JM
Clin Ther; 2014 Sep; 36(9):1233-1243.e1. PubMed ID: 25066668
[TBL] [Abstract][Full Text] [Related]
23. Improved outcome of ventilator-associated pneumonia caused by methicillin-resistant Staphylococcus aureus in a trauma population.
Gonzalez RP; Rostas J; Simmons JD; Allen J; Frotan MA; Brevard SB
Am J Surg; 2013 Mar; 205(3):255-8; discussion 258. PubMed ID: 23375761
[TBL] [Abstract][Full Text] [Related]
24. Cost analysis of switching from i.v. vancomycin to p.o. linezolid for the management of methicillin-resistant Staphylococcus species.
McCollum M; Rhew DC; Parodi S
Clin Ther; 2003 Dec; 25(12):3173-89. PubMed ID: 14749155
[TBL] [Abstract][Full Text] [Related]
25. Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.
Maclayton DO; Hall RG
Ann Pharmacother; 2007 Feb; 41(2):235-44. PubMed ID: 17299012
[TBL] [Abstract][Full Text] [Related]
26. Linezolid limits burden of methicillin-resistant Staphylococcus aureus in biofilm of tracheal tubes.
Fernández-Barat L; Ferrer M; Sierra JM; Soy D; Guerrero L; Vila J; Li Bassi G; Cortadellas N; Martínez-Olondris P; Rigol M; Esperatti M; Luque N; Saucedo LM; Agustí C; Torres A
Crit Care Med; 2012 Aug; 40(8):2385-9. PubMed ID: 22622402
[TBL] [Abstract][Full Text] [Related]
27. Linezolid in VAP by MRSA: a better choice?
Ioanas M; Lode H
Intensive Care Med; 2004 Mar; 30(3):343-6. PubMed ID: 14767588
[No Abstract] [Full Text] [Related]
28. Nosocomial pneumonia: therapy is just not good enough.
Bauer TT
Chest; 2003 Nov; 124(5):1632-4. PubMed ID: 14605025
[No Abstract] [Full Text] [Related]
29. Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Puzniak LA; Morrow LE; Huang DB; Barreto JN
Clin Ther; 2013 Oct; 35(10):1557-70. PubMed ID: 24011955
[TBL] [Abstract][Full Text] [Related]
30. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan.
Kohno S; Yamaguchi K; Aikawa N; Sumiyama Y; Odagiri S; Aoki N; Niki Y; Watanabe S; Furue M; Ito T; Croos-Dabrera R; Tack KJ
J Antimicrob Chemother; 2007 Dec; 60(6):1361-9. PubMed ID: 17913720
[TBL] [Abstract][Full Text] [Related]
31. Early switch and early discharge opportunities in intravenous vancomycin treatment of suspected methicillin-resistant staphylococcal species infections.
Parodi S; Rhew DC; Goetz MB
J Manag Care Pharm; 2003; 9(4):317-26. PubMed ID: 14613450
[TBL] [Abstract][Full Text] [Related]
32. What is the best therapeutic approach to methicillin-resistant Staphylococcus aureus pneumonia?
Peyrani P; Ramirez J
Curr Opin Infect Dis; 2015 Apr; 28(2):164-70. PubMed ID: 25692268
[TBL] [Abstract][Full Text] [Related]
33. Linezolid use in ventilator-associated pneumonia: look at the body weight of your patient!
De Pascale G; Fortuna S; Navarra P; Antonelli M
Minerva Anestesiol; 2012 Dec; 78(12):1418-9. PubMed ID: 22858883
[No Abstract] [Full Text] [Related]
34. A comparison of costs and hospital length of stay associated with intravenous/oral linezolid or intravenous vancomycin treatment of complicated skin and soft-tissue infections caused by suspected or confirmed methicillin-resistant Staphylococcus aureus in elderly US patients.
McCollum M; Sorensen SV; Liu LZ
Clin Ther; 2007 Mar; 29(3):469-77. PubMed ID: 17577468
[TBL] [Abstract][Full Text] [Related]
35. The ZEPHyR study: a randomized comparison of linezolid and vancomycin for MRSA pneumonia.
Chavanet P
Med Mal Infect; 2013 Dec; 43(11-12):451-5. PubMed ID: 24238896
[TBL] [Abstract][Full Text] [Related]
36. Linezolid versus vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia: controversy continues.
Masuta K; Oba Y; Iwata K
Clin Infect Dis; 2012 Jul; 55(1):161. PubMed ID: 22460960
[No Abstract] [Full Text] [Related]
37. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.
Wunderink RG; Niederman MS; Kollef MH; Shorr AF; Kunkel MJ; Baruch A; McGee WT; Reisman A; Chastre J
Clin Infect Dis; 2012 Mar; 54(5):621-9. PubMed ID: 22247123
[TBL] [Abstract][Full Text] [Related]
38. Co-emergence of linezolid-resistant Staphylococcus aureus and Enterococcus faecium in a patient with methicillin-resistant S. aureus pneumonic sepsis.
An D; Lee MY; Jeong TD; Sung H; Kim MN; Hong SB
Diagn Microbiol Infect Dis; 2011 Feb; 69(2):232-3. PubMed ID: 21251573
[No Abstract] [Full Text] [Related]
39. Linezolid versus vancomycin for methicillin-resistant Staphylococcus aureus infections.
Johnson JR
Clin Infect Dis; 2003 Jan; 36(2):236-7. PubMed ID: 12522761
[No Abstract] [Full Text] [Related]
40. Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus.
Wunderink RG; Mendelson MH; Somero MS; Fabian TC; May AK; Bhattacharyya H; Leeper KV; Solomkin JS
Chest; 2008 Dec; 134(6):1200-1207. PubMed ID: 18719064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]